A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2b Study of OTO-104 Given as a Single Intratympanic Injection in Subjects with Unilateral Menieres Disease
This study is recruiting participants 18 - 80yo who have been diagnosed with unilateral Meniere\\\\\\\'s Disease and are experiencing vertigo. If you meet enrollment criteria, you will be randomized to receive an intratympanic (eardrum) injection of either the study drug (OTO-104) or a placebo and will attend 6 clinic visits over a 5 month period. For more information, please call Leigh Anne Marshall at 352.273.5178; email: email@example.com
KeywordsMenieres disease, vertigo, ear, ringing, dizzy
Principal InvestigatorPatrick Antonelli, M.D.
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.